Nanatinostat
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nanatinostat, covering 2025-01-20 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas [Phase 2]